Catalog Number 515052 |
Device Problem
Packaging Problem (3007)
|
Patient Problems
No Patient Involvement (2645); No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/22/2020 |
Event Type
malfunction
|
Manufacturer Narrative
|
Date of event: unknown.The date received by manufacturer has been used for this field.There were multiple lot numbers reported to be involved.The information for each lot number is as follows: medical device lot #: 2002101 medical device expiration date: 2021-01-31 device manufacture date: 2020-02-10 medical device lot #: unknown medical device expiration date: unknown device manufacture date: unknown a device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.(b)(4).
|
|
Event Description
|
It was reported that 3 bd phaseal optima injectors (n35-o) experienced a damaged or open unit package/seal where sterility was compromised.The following information was provided by the initial reporter: material no: 515052 batch no: 2002101;unknown customer uses 70% ipa and (b)(6) bleach wipes to wipe down everything going into the anti-room and clean room.It was noticed that the packaging of the injectors started to flake off and left white specks onto the injector.
|
|
Manufacturer Narrative
|
The following fields were updated due to additional information: d10 device available for eval?: yes.D10 returned to manufacturer on: 11/30/2020.H6 investigation: two samples were provided to our quality team for investigation.Upon visual inspection, white particles can be observed on the surface of the injector hub of only one sample.It was noted the packaging was wrinkled.A device history review was performed for lot 2002101, no deviations or non-conformances related to the reported issue were identified during the manufacturing process.Fifteen retained samples of the same lot were used for additional evaluation.The product was inspected and no particles were observed on any of the injectors.Sterilization testing was reviewed and results were found to be within specification.Through our investigation the particles were identified to consist of tyvek paper which is used in the packaging of this product.Manufacturing for this product is performed in a clean room which is kept under a positive pressure to reduce the chance of foreign matter.A review of manufacturing records established that all cleaning for the packaging lines were performed according to procedure.
|
|
Event Description
|
It was reported that 3 bd phaseal optima injectors (n35-o) experienced a damaged or open unit package/seal where sterility was compromised.The following information was provided by the initial reporter: material no: 515052; batch no: 2002101;unknown.Customer uses 70% ipa and clorox bleach wipes to wipe down everything going into the anti-room and clean room.It was noticed that the packaging of the injectors started to flake off and left white specks onto the injector.
|
|
Search Alerts/Recalls
|